Lynch Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.5M | Buy |
108,700
+600
| +0.6% | +$41.4K | 2.65% | 11 |
|
2025
Q1 | $7.51M | Buy |
108,100
+1,150
| +1% | +$79.9K | 3.37% | 7 |
|
2024
Q4 | $9.2M | Buy |
106,950
+650
| +0.6% | +$55.9K | 3.73% | 5 |
|
2024
Q3 | $12.7M | Buy |
106,300
+1,500
| +1% | +$179K | 5.32% | 2 |
|
2024
Q2 | $15M | Sell |
104,800
-2,000
| -2% | -$285K | 6.39% | 2 |
|
2024
Q1 | $13.7M | Hold |
106,800
| – | – | 6.45% | 2 |
|
2023
Q4 | $11M | Hold |
106,800
| – | – | 6.33% | 2 |
|
2023
Q3 | $9.71M | Hold |
106,800
| – | – | 6.38% | 2 |
|
2023
Q2 | $8.64M | Hold |
106,800
| – | – | 5.56% | 2 |
|
2023
Q1 | $8.5M | Hold |
106,800
| – | – | 6.1% | 2 |
|
2022
Q4 | $7.23M | Hold |
106,800
| – | – | 6.22% | 3 |
|
2022
Q3 | $5.32M | Hold |
106,800
| – | – | 4.77% | 6 |
|
2022
Q2 | $5.95M | Hold |
106,800
| – | – | 4.87% | 6 |
|
2022
Q1 | $5.93M | Hold |
106,800
| – | – | 4.24% | 7 |
|
2021
Q4 | $5.98M | Buy |
+106,800
| New | +$5.98M | 4.15% | 7 |
|